The neuronal membrane as a key factor in neurodegeneration.

The neuronal membrane as a key factor in neurodegeneration.

Bibliographic Details
Main Author:	Raquel eMarin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2013-07-01
Series:	Frontiers in Physiology
Subjects:	Estrogen Receptor beta Parkinson Disease Alzheimer's disease Amyloid beta LRP neuroligin
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphys.2013.00188/full

Similar Items

Editorial on, Amyloid-beta clearance in Alzheimer’s disease.
by: Robert eMarr
Published: (2014-11-01)

Neuroprotective effect of genistein against beta amyloid-induced neurotoxicity
by: Oh Young Bang, et al.
Published: (2004-06-01)

Liver Dysfunction as a Novel Player in Alzheimer’s Progression: Looking Outside the Brain
by: Lisbell D. Estrada, et al.
Published: (2019-07-01)

Deficient Wnt Signaling and Synaptic Vulnerability in Alzheimer’s Disease: Emerging Roles for the LRP6 Receptor
by: Johanna Buechler, et al.
Published: (2018-10-01)

Periodontal Disease and Neurodegeneration: The Possible Pathway and Contribution from Periodontal Infections
by: Rajeev Ranjan, et al.
Published: (2018-01-01)

Étude de la relation entre les oligomères amyloïde-bêta et la protéine d'adhésion synaptique Neuroligine-1
by: Dufort-Gervais, Julien
Published: (2019)

Role of the N-Terminal Hydrophilic Region of Amyloid Beta Peptide in Amyloidogenesis, Membrane Interaction and Toxicity Associated with Alzheimer’s Disease

The role of type 2 diabetes in neurodegeneration
by: Giuseppe Verdile, et al.
Published: (2015-12-01)

Membranes biomimétiques pour la caractérisation de nouveaux agents thérapeutiques : application à la maladie d'Alzheimer
by: Smeralda, Willy
Published: (2019)

Early Effects of the Soluble Amyloid β<sub>25-35</sub> Peptide in Rat Cortical Neurons: Modulation of Signal Transduction Mediated by Adenosine and Group I Metabotropic Glutamate Receptors
by: Carlos Alberto Castillo, et al.
Published: (2021-06-01)

A Human Embryonic Stem Cell Model of Aβ-Dependent Chronic Progressive Neurodegeneration
by: Teresa Ubina, et al.
Published: (2019-09-01)

Investigation of low amyloid level toxicity effects on the function of hippocampal neurons
by: Popugaeva Elena, et al.
Published: (2015-10-01)

Intraventricular infusion of clusterin ameliorated cognition and pathology in Tg6799 model of Alzheimer’s disease
by: Xue-Mei Qi, et al.
Published: (2018-01-01)

Catechins as Tools to Understand the Molecular Basis of Neurodegeneration
by: Karla Martinez Pomier, et al.
Published: (2020-08-01)

Uptake of Aβ by OATPs might be a new pathophysiological mechanism of Alzheimer disease
by: Jinhua Wen, et al.
Published: (2021-09-01)

BETA AMYLOID POLYCLONAL ANTIBODY IMMUNOGENICITY AS EARLY DEVELOPMENT STUDY OF EARLY DIAGNOSIS FOR ALZHEIMER’S DISEASE
by: M. Rasjad Indra, et al.
Published: (2017-01-01)

Mechanism mediating oligomeric Aβ clearance by naïve primary microglia
by: Cheng-Ning Yang, et al.
Published: (2011-06-01)

LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in Alzheimer’s disease
by: Carlos eSpuch, et al.
Published: (2012-07-01)

The Dual Role of Kinin/Kinin Receptors System in Alzheimer’s Disease
by: Bingyuan Ji, et al.
Published: (2019-10-01)

Amyloid Beta Peptide Induces D-serine Dependent NMDAR Dysfunction in the Mouse Hippocampus
by: Wang, Boyang
Published: (2016)

Sinomenine inhibits amyloid beta-induced astrocyte activation and protects neurons against indirect toxicity
by: Deepali Singh, et al.
Published: (2020-03-01)

Tacrine, trolox and tryptoline as lead compounds for the design and synthesis of multi-target drugs for Alzheimer's disease therapy
by: Teponnou, Gerard A. Kenfack
Published: (2016)

Amyloid Cascade Hypothesis Perspective on Alzheimer's Disease

Effects of soluble β-amyloid on the release of neurotransmitters from rat brain synaptosomes.
by: Guendalina eOlivero, et al.
Published: (2014-07-01)

Alternative platelet activation pathways and their role in neurodegenerative diseases
by: Paula Ferrer-Raventós, et al.
Published: (2021-11-01)

Effect of Cholesterol on Membrane Fluidity and Association of Aβ Oligomers and Subsequent Neuronal Damage: A Double-Edged Sword
by: Eduardo J. Fernández-Pérez, et al.
Published: (2018-08-01)

Piceatannol, a natural analogue of resveratrol, effectively reduces beta-amyloid levels via activation of alpha-secretase and matrix metalloproteinase-9
by: Boyoung Choi, et al.
Published: (2016-05-01)

Maladie d'Alzheimer : Impact extracellulaire et intracellulaire du peptide ß-amyloïde sur la transmission synaptique glutamatergique
by: Rolland, Marta
Published: (2016)

Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity
by: Stefanie A.G. Black, et al.
Published: (2014-08-01)

Postsynaptic Receptors for Amyloid-β Oligomers as mediators of neuronal damage in Alzheimer's Disease
by: Margarita C. Dinamarca, et al.
Published: (2012-12-01)

Importance of GPCR-Mediated Microglial Activation in Alzheimer’s Disease
by: Md. Ezazul Haque, et al.
Published: (2018-08-01)

The neuroprotective effect of immune serum of adeno-associated virus vaccine containing Aβ1-15 gene on amyloid toxicity
by: Ling-Yun Liu, et al.
Published: (2013-01-01)

Differential Effect of Amyloid Beta1-40 on Short-term and Long-term Plasticity in Dentate Gyrus of a Rat Model of Alzheimer Disease
by: Javad Fahanik-Babaei, et al.
Published: (2020-07-01)

Acute intracerebral treatment with amyloid-beta (1-42) alters the profile of neuronal oscillations that accompany LTP induction and results in impaired LTP in freely behaving rats
by: Alexander Nikolai eKalweit, et al.
Published: (2015-05-01)

The Role of NMDA Receptors in Alzheimer’s Disease
by: Jinping Liu, et al.
Published: (2019-02-01)

The Acute Effects of Amyloid-Beta1–42 on Glutamatergic Receptor and Transporter Expression in the Mouse Hippocampus
by: Jason H. Y. Yeung, et al.
Published: (2020-01-01)

The role of astrocytes in amyloid production and Alzheimer's disease
by: Georgia R. Frost, et al.
Published: (2017-01-01)

Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
by: Md. Sahab Uddin, et al.
Published: (2018-01-01)

Immune cell responses to amyloid-beta proteins: What is the extent and implications of amyloid-beta induced cytotoxicity in microglial cells and peripheral blood mononuclear cells?
by: Cao, A.
Published: (2017-07-01)

Mitochondrial Manipulation and the Quest for Alzheimer's Treatments
by: Russell H. Swerdlow
Published: (2015-04-01)

Cannot write session to /tmp/vufind_sessions/sess_g4ufm3aur3igo0m1rl0pnn5daj